Share on StockTwits

Exactech (NASDAQ:EXAC) CFO Joel C. Phillips sold 5,000 shares of the company’s stock in a transaction dated Tuesday, June 10th. The shares were sold at an average price of $24.77, for a total transaction of $123,850.00. Following the sale, the chief financial officer now directly owns 84,287 shares in the company, valued at approximately $2,087,789. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link.

Shares of Exactech (NASDAQ:EXAC) traded down 0.24% on Thursday, hitting $24.98. 24,539 shares of the company’s stock traded hands. Exactech has a 52-week low of $18.34 and a 52-week high of $25.36. The stock has a 50-day moving average of $22.62 and a 200-day moving average of $23.19. The company has a market cap of $341.2 million and a P/E ratio of 22.16.

Exactech (NASDAQ:EXAC) last issued its quarterly earnings data on Monday, April 21st. The company reported $0.30 earnings per share for the quarter, beating the analysts’ consensus estimate of $0.29 by $0.01. The company had revenue of $63.30 million for the quarter, compared to the consensus estimate of $63.05 million. During the same quarter last year, the company posted $0.29 earnings per share. Exactech’s revenue was up 6.7% compared to the same quarter last year. On average, analysts predict that Exactech will post $1.21 earnings per share for the current fiscal year.

Exactech, Inc develops, manufactures and sells orthopedic implant devices, related surgical instruments and biological material and services to make patients more mobile.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.